Satoshi Nara

16PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumoursRegenerative medicine (incl. stem cells)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 23, 2026
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer.

|Jul 24, 2026
A perioperative immunonutritional nomogram for survival prediction beyond tumor-node-metastasis classification in ampullary adenocarcinoma.

|Aug 16, 2024
Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after FOLFIRINOX or gemcitabine plus nab-paclitaxel chemotherapy: A multicenter retrospective cohort study (PC-CURE-1).

Naohiro Okano, Manabu Kawai, Makoto Ueno

|Apr 28, 2024
Impact of Surgical Margin Status on Survival and Recurrence After Pancreaticoduodenectomy for Distal Cholangiocarcinoma: Is Microscopic Residual Tumor (R1) Associated with Higher Rates of Local Recurrence?

Ryosuke Umino, Satoshi Nara, Takahiro Mizui

|Feb 14, 2024
Pathological complete response of initially unresectable multiple liver metastases achieved using combined peptide receptor radionuclide therapy and somatostatin analogs following pancreatic neuroendocrine tumor resection: a case report.

Ryosuke Umino, Satoshi Nara, Noritoshi Kobayashi

|Aug 20, 2023
Adjuvant and neoadjuvant chemotherapy for biliary tract cancer: a review of randomized controlled trials.

Kohei Nakachi, Naoto Gotohda, Etsuro Hatano

Pageof 3

Frequent Collaborators

2 joint publications

Nobuyoshi Hiraoka

1 joint publications

Y Kishi

1 joint publications

Akira Imaizumi

1 joint publications

Hidetoshi Kitamura